The United States Food and Drug Administration approved Bayer's blood thinner San Arbo to decrease the risk of dangerous internal bleeding

Drug pricing and affordability, FDA drug approvals, clinical trial design, drug shortages, insurer coverage, pharmaceutical regulation, and medication access.